Q9998 Injection ustekinumab-aekn, 1 milligrams
Q-Codes
Also known as: ustekinumab biosimilar, IL-12/23 inhibitor, Wezlana
Injection of ustekinumab-aekn (Wezlana), a biosimilar to ustekinumab, administered at 1 milligram per dose.
Clinical Context
Used for psoriasis, psoriatic arthritis, and Crohn's disease as biosimilar alternative to reference ustekinumab.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.